Mirum(MIRM) - 2024 Q4 - Annual Results

Mirum Pharmaceuticals: Transforming Lives in Rare Disease J a n u a r y 2 0 2 5 Forward-Looking Statements This presentation contains "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to managem include all statements other than statements of historical fact contained in this presentation, including information concerning our business strategy, objectives and oppor opportunities for LIVMARLI, CHOLBAM, chenodiol, and Mirum's clinica ...